Rules & regulations: MACs get to the point, meet to pin down trigger point injections

Why This Topic Matters

Medicare coverage policy can affect whether trigger point injection services are considered payable and what supporting documentation or diagnostic categories may be addressed in future contractor guidance. Readers who follow Medicare LCD development will want to know that contractors are actively evaluating this topic and may issue new policy updates.

Article Sections

1. Meeting overview and possible policy changes

   Summarizes the contractor advisory committee meeting and the possibility of future Medicare coverage guidance for trigger point injections. It also notes the roles of contractors, medical directors, and subject matter experts in the review process.

2. Definitions and terminology related to trigger point injections

   Discusses the terminology and clinical concepts reviewed during the meeting, including how the panel approached related definitions and the scope of terms considered in a future policy.

3. Conservative treatment considerations before trigger point injections

   Covers the discussion of whether conservative care should be required before treatment and the general viewpoints raised by participants about sequencing care.

4. Additional evidence topics discussed by the panel

   Reviews several broader evidence themes addressed during the meeting, including injectant considerations, follow-up treatment support, and the strength of evidence for covered diagnoses.

5. How to monitor MAC policy updates

   Explains where readers can look for proposed and finalized Medicare coverage updates and how to follow local coverage activity for their contractor area.